Total Payments
$6,231
2024 Payments
$824.32
Companies
43
Transactions
318
Medicare Patients
6,541
Medicare Billing
$567,026
Payment Breakdown by Category
Food & Beverage$6,208 (99.6%)
Education$23.11 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,208 | 316 | 99.6% |
| Education | $23.11 | 2 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $1,237 | 70 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $537.85 | 26 | $0 (2024) |
| PFIZER INC. | $424.33 | 24 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $357.82 | 17 | $0 (2023) |
| Axonics, Inc. | $357.10 | 8 | $0 (2023) |
| TOLMAR Pharmaceuticals, Inc. | $292.84 | 19 | $0 (2022) |
| Medtronic USA, Inc. | $272.85 | 20 | $0 (2020) |
| Allergan, Inc. | $238.39 | 16 | $0 (2022) |
| Blue Earth Diagnostics Limited | $214.94 | 11 | $0 (2021) |
| Boston Scientific Corporation | $210.74 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $824.32 | 42 | Sumitomo Pharma America, Inc. ($180.14) |
| 2023 | $1,014 | 43 | Sumitomo Pharma America, Inc. ($357.71) |
| 2022 | $676.48 | 37 | Astellas Pharma US Inc ($101.47) |
| 2021 | $768.06 | 41 | Astellas Pharma US Inc ($173.45) |
| 2020 | $668.81 | 35 | Astellas Pharma US Inc ($216.06) |
| 2019 | $842.95 | 39 | Astellas Pharma US Inc ($175.81) |
| 2018 | $663.59 | 40 | PFIZER INC. ($211.26) |
| 2017 | $773.11 | 41 | Astellas Pharma US Inc ($239.50) |
All Payment Transactions
318 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: HORMONE THERAPY | ||||||
| 12/03/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: HORMONE THERAPY | ||||||
| 11/25/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $2.00 | General |
| Category: HORMONE THERAPY | ||||||
| 11/13/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: ONCOLOGY | ||||||
| 11/12/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $31.92 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 11/06/2024 | 180 Medical, Inc. | GENTLECATH (Device) | Food and Beverage | In-kind items and services | $25.70 | General |
| Category: CONTINENCE CARE | ||||||
| 10/30/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: UROTHELIAL CANCER | ||||||
| 10/29/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $25.04 | General |
| Category: UROLOGY | ||||||
| 10/23/2024 | Laborie Medical Technologies Corp. | EndoSheath Technology (Device) | Food and Beverage | Cash or cash equivalent | $22.59 | General |
| Category: Urology | ||||||
| 10/14/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: UROLOGY | ||||||
| 10/08/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 09/25/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: UROLOGY | ||||||
| 09/24/2024 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: ONCOLOGY | ||||||
| 09/09/2024 | 180 Medical, Inc. | GENTLECATH (Device) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: CONTINENCE CARE | ||||||
| 09/06/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $23.77 | General |
| Category: UROLOGY | ||||||
| 08/29/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 08/27/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $25.38 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 08/13/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $4.22 | General |
| Category: UROLOGY | ||||||
| 08/06/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: ONCOLOGY | ||||||
| 07/30/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: ONCOLOGY | ||||||
| 07/29/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: HORMONE THERAPY | ||||||
| 07/16/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: UROLOGY | ||||||
| 07/08/2024 | 180 Medical, Inc. | — | Food and Beverage | In-kind items and services | $14.91 | General |
| 06/11/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $25.05 | General |
| Category: UROTHELIAL CANCER | ||||||
| 06/04/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,338 | 1,874 | $414,330 | $132,236 |
| 2022 | 18 | 1,436 | 2,000 | $429,620 | $135,096 |
| 2021 | 21 | 1,966 | 2,748 | $478,965 | $167,639 |
| 2020 | 22 | 1,801 | 2,452 | $367,005 | $132,056 |
Total Patients
6,541
Total Services
9,074
Medicare Billing
$567,026
Procedure Codes
81
All Medicare Procedures & Services
81 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 350 | 552 | $82,900 | $36,088 | 43.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 194 | 439 | $57,100 | $28,062 | 49.1% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 177 | 194 | $81,300 | $12,792 | 15.7% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 170 | 182 | $29,120 | $12,384 | 42.5% |
| 52353 | Crushing of stone of ureter using an endoscope | Facility | 2023 | 22 | 27 | $27,000 | $8,933 | 33.1% |
| 52601 | Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | Facility | 2023 | 12 | 12 | $24,000 | $7,023 | 29.3% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 29 | 42 | $42,000 | $5,195 | 12.4% |
| 52351 | Diagnostic exam of bladder, urethra, and ureter or kidney using an endoscope | Facility | 2023 | 14 | 15 | $10,500 | $3,686 | 35.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 32 | 34 | $8,500 | $3,603 | 42.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 42 | 42 | $10,500 | $3,431 | 32.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 33 | 34 | $6,800 | $3,421 | 50.3% |
| 52005 | Insertion of tube into ureter using an endoscope through bladder area | Facility | 2023 | 15 | 16 | $8,800 | $1,718 | 19.5% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 14 | 14 | $4,900 | $1,489 | 30.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $3,600 | $1,412 | 39.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 13 | 13 | $3,250 | $815.64 | 25.1% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 124 | 140 | $1,400 | $551.60 | 39.4% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 12 | 28 | $1,260 | $460.00 | 36.5% |
| 76856 | Complete ultrasound scan of pelvis | Facility | 2023 | 15 | 15 | $3,750 | $400.50 | 10.7% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 43 | 48 | $2,400 | $387.45 | 16.1% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2023 | 15 | 15 | $5,250 | $383.10 | 7.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 383 | 569 | $86,150 | $38,355 | 44.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 163 | 397 | $45,825 | $22,995 | 50.2% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 206 | 248 | $36,905 | $20,536 | 55.6% |
| 52353 | Crushing of stone of ureter using an endoscope | Facility | 2022 | 29 | 35 | $35,000 | $11,426 | 32.6% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2022 | 148 | 170 | $68,000 | $10,798 | 15.9% |
About Dr. Jeffrey Greski, DO
Dr. Jeffrey Greski, DO is a Urology healthcare provider based in Rochester Hills, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1073619441.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Greski, DO has received a total of $6,231 in payments from pharmaceutical and medical device companies, with $824.32 received in 2024. These payments were reported across 318 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($6,208).
As a Medicare-enrolled provider, Greski has provided services to 6,541 Medicare beneficiaries, totaling 9,074 services with total Medicare billing of $567,026. Data is available for 4 years (2020–2023), covering 81 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Rochester Hills, MI
- Active Since 09/15/2006
- Last Updated 07/08/2007
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1073619441
Products in Payments
- XTANDI (Drug) $889.62
- ORGOVYX (Drug) $437.68
- INTERSTIM (Device) $435.68
- XIAFLEX (Biological) $378.12
- Myrbetriq (Drug) $314.21
- ELIGARD (Drug) $292.84
- BOTOX (Biological) $235.63
- Axumin (Drug) $214.94
- Xtandi (Drug) $207.41
- Bulkamid (Device) $186.45
- GEMTESA (Drug) $184.60
- Androgel (Drug) $157.65
- Axonics (Device) $150.38
- BRIDION (Drug) $129.75
- MYRBETRIQ (Drug) $105.17
- TLANDO (Drug) $99.02
- NOCDURNA (Drug) $98.62
- AMS (Device) $83.21
- PROVENGE (Drug) $79.56
- VESICARE (Drug) $67.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.